Current data has a 15-minute delay. Please / to get real-time quotes.
icon

Mesoblast

MESO

MESO Mesoblast NASDAQ
Add to watchlist
14.60
0.00 (0.00 %)
At close : Jan 03, 16:00 ET
--
  • Post market
  • 20:00 ET
    Summary
    Options
    Financials
    News
    Filings
    Profile
    MESO Chart
    See on advanced chart >
    All
    D
    W
    M
    5m
    • Volume 996.27k
    • Turnover 14.39M
    • P/E(TTM) --
    • Turnover % 3.83%
    • P/E(Static) --
    • Market Cap 444.26M
    • P/B 5.27
    • Shares 30.43M
    • 52 Week Range
      12.51
      41.31
    • Day Range
      13.74
      14.87

    About

    Mesoblast Limited was incorporated on June 8, 2004 in Australia. The company is a world leader in developing allogeneic cellular medicines. The Company has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad...
    • Highlight
      A global leader in allogeneic cellular medicines for inflammatory diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      11/13/2015
    • Established Date
      06/08/2004
    • Full-time Employees
      73
    • Address
      Level 38 55 Collins Street Melbourne VIC 3000 Australia
    • Tel
      61-3-96396036
    • Website
    • Fiscal Year End Date
      06/30
    • Security Type
      American Depositary Receipt (Common Stock)

    Option Block Monitor

    You Can Understand Stocks with AI.
    Why NVDA surged 16.40%?
    Because it
    fork
    logo
    AInvest
    Aime Coplilot
    Invest Smarter With AI Power.
    Open App
    All
    QUICK
    Daily
    Weekly
    Monthly
    Minutes
    5 minutes
    15 minutes
    30 minutes
    Ranges
    1 Day
    1 Week
    1 Month
    1 Year
    YTD